OBLIGING SURGEONS TO ENHANCE: NEGLIGENCE LIABILITY FOR UNCORRECTED FATIGUE AND PROBLEMS WITH PROVING CAUSATION

被引:2
作者
Goold, Imogen [1 ,2 ]
Maslen, Hannah [3 ,4 ]
机构
[1] Univ Oxford, Fac Law, Oxford OX1 2JD, England
[2] Univ Oxford St Annes Coll, Oxford OX2 6HS, England
[3] Univ Oxford, Oxford Martin Sch, Oxford OX1 2JD, England
[4] Univ Oxford New Coll, Oxford OX1 3BN, England
关键词
Causation; cognitive enhancement; medical; modafinil; negligence; surgeon; HEALTHY-VOLUNTEERS; PHARMACOLOGICAL ENHANCEMENT; PRESCRIPTION STIMULANTS; MODAFINIL; PERFORMANCE; SLEEP; WAKEFULNESS; STUDENTS; MIDDLE;
D O I
10.1093/medlaw/fwu028
中图分类号
D9 [法律]; DF [法律];
学科分类号
0301 ;
摘要
Increasing interest in the use of cognitive enhancing pharmaceuticals, such as modafinil, has led to considerable ethical debate about issues around authenticity, fairness and even whether there is a moral obligation to enhance. This latter question has raised questions as to whether there might be a legal obligation to enhance. We have argued elsewhere that the law will not oblige a professional to self-enhance. In this article, we explore a second reason why a claim of negligence for a failure to enhance would be unlikely to succeed: the problem of establishing causation. As the science on enhancers and what they are capable of currently stands, it would be almost invariably impossible to establish a causal link between failure to enhance to redress fatigue, and the harm that allegedly resulted. Even where a link between fatigue and harm can be established, it will be extremely difficult to show that taking an enhancer would have averted the harm. We focus on the most likely context in which such claims might arise-clinical negligence-and on the most efficacious enhancing drug currently available-modafinil.
引用
收藏
页码:427 / 454
页数:28
相关论文
共 38 条
[1]  
[Anonymous], 2011, BBC NEWS 1109
[2]  
[Anonymous], COGNITIVE ENHANCEMEN
[3]   When the boss turns pusher: a proposal for employee protections in the age of cosmetic neurology [J].
Appel, J. M. .
JOURNAL OF MEDICAL ETHICS, 2008, 34 (08) :616-618
[4]  
Benumof Jonathan L, 2004, Curr Opin Anaesthesiol, V17, P21, DOI 10.1097/00001503-200402000-00005
[5]  
Caldwell JA, 2005, DEXTROAMPHETAMINE MO
[6]   Autonomy and the Unintended Legal Consequences of Emerging Neurotherapies [J].
Chandler, Jennifer A. .
NEUROETHICS, 2013, 6 (02) :249-263
[7]   Efficacy and Safety of Modafinil in the Treatment of Cancer-Related Fatigue [J].
Cooper, Maryann R. ;
Bird, Heather M. ;
Steinberg, Michael .
ANNALS OF PHARMACOTHERAPY, 2009, 43 (04) :721-725
[8]   Reining In the Pharmacological Enhancement Train: We Should Remain Vigilant about Regulatory Standards for Prescribing Controlled Substances [J].
Drabiak-Syed, Katherine .
JOURNAL OF LAW MEDICINE & ETHICS, 2011, 39 (02) :272-279
[9]   Must the Surgeon Take the Pill? Negligence Duty in the Context of Cognitive Enhancement [J].
Goold, Imogen ;
Maslen, Hannah .
MODERN LAW REVIEW, 2014, 77 (01) :60-86
[10]   Effect of Modafinil on Impairments in Neurobehavioral Performance and Learning Associated with Extended Wakefulness and Circadian Misalignment [J].
Grady, Scott ;
Aeschbach, Daniel ;
Wright, Kenneth P., Jr. ;
Czeisler, Charles A. .
NEUROPSYCHOPHARMACOLOGY, 2010, 35 (09) :1910-1920